The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Six months of isoflavone supplement increases fat-free mass in obese–sarcopenic postmenopausal women: a randomized double-blind controlled trial
Abstract
Objective The aim of this study was to verify if six months of isoflavone supplementation could increase fat-free mass (FFM) and muscle mass index (MMI=appendicular FFM/height(2)) in obese-sarcopenic postmenopausal women.Design Double-blind randomized study.Subject Eighteen sarcopenic-obese women completed the study (12 on isoflavones and six on placebo). Body composition was measured by dual-energy X-ray absorptiometry. Subjects ingested 70 mg of isoflavones per day (44 mg of diadzein, 16 mg glycitein and 10 mg genestein) or a placebo for 24 weeks.Results The isoflavone group increased significantly appendicular (P=0.034), leg (P=0.016) FFM and MMI (P=0.037), but not the placebo group.Conclusion Six months of isoflavone supplementation increased FFM and MMI in obese-sarcopenic postmenopausal women.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Six studies assessed the effectiveness of exercise interventions,29–32,36,38 2 studies assessed different nutritional interventions,28,37 and 3 studies evaluated the effect of a nutritional intervention in combination with training.33–35”
From Nutritional and exercise interventions in individuals with sarcopenic obesity around retirement age: a systematic review and meta-analysis (2023) · cites this paper as [28]
In the citing paper
“Aubertin-Leheudre et al28 found that isoflavone supplementation (70 g/d) in postmenopausal women significantly improved leg fat-free mass (P = 0.034), appendicular fat-free mass (P = 0.016), and muscle mass index (P = 0.037), as assessed by dual-energy x-ray absorptiometry.”
From Nutritional and exercise interventions in individuals with sarcopenic obesity around retirement age: a systematic review and meta-analysis (2023) · cites this paper as [28]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 1×
“Class I sarcopenia is considered as a MMI between one or more standard deviations below the values of young adults from a reference population (Baumgartner et al., 1998; Janssen et al., 2002).”
BackgroundJanssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139 · cited 1×
“Class I sarcopenia is considered as a MMI between one or more standard deviations below the values of young adults from a reference population (Baumgartner et al., 1998; Janssen et al., 2002).”
BackgroundSarcopenic Obesity Predicts Instrumental Activities of Daily Living Disability in the Elderly
Baumgartner, R. N., Wayne, S. J., Waters, D. L., Janssen, I., Gallagher, D., & Morley, J. E. (2004) · Obesity Research · doi:10.1038/oby.2004.250 · Cited by 937
Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause
Haarbo, J., Marslew, U., Gotfredsen, A., & Christiansen, C. (1991) · Metabolism · doi:10.1016/0026-0495(91)90037-w · Cited by 441
Fat and protein redistribution with aging: metabolic considerations
Beaufrère, B., & Morio, B. (2000) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601025 · Cited by 289
Hermansen, K., Søndergaard, M., Høie, L., Carstensen, M., & Brock, B. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.228 · Cited by 264
Estrogen Receptor Alpha mRNA in Human Skeletal Muscles
LEMOINE, S., GRANIER, P., TIFFOCHE, C., RANNOU-BEKONO, F., THIEULANT, M.-L., & DELAMARCHE, P. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000053654.14410.78 · Cited by 201
Walker, H. A., Dean, T. S., Sanders, T. A. B., Jackson, G., Ritter, J. M., & Chowienczyk, P. J. (2001) · Circulation · doi:10.1161/01.cir.103.2.258 · Cited by 189
van der Schouw, Y. T., Kreijkamp‐Kaspers, S., Peeters, P. H. M., Keinan‐Boker, L., Rimm, E. B., & Grobbee, D. E. (2005) · Circulation · doi:10.1161/01.cir.0000153814.87631.b0 · Cited by 158
Cited by
Changes in muscle mass and strength after menopause.
Maltais, M. L., Desroches, J., & Dionne, I. J. (2009) · PubMed · Cited by 589
Self-citationISSN exercise & sport nutrition review: research & recommendations
Kreider, R. B., Wilborn, C. D., Taylor, L., Campbell, B., Almada, A. L., Collins, R., Cooke, M., Earnest, C. P., Greenwood, M., Kalman, D. S., et al. (2010) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-7-7 · Cited by 428
Menopause and sarcopenia: A potential role for sex hormones
Messier, V., Rabasa-Lhoret, R., Barbat-Artigas, S., Elisha, B., Karelis, A. D., & Aubertin-Leheudre, M. (2011) · Maturitas · doi:10.1016/j.maturitas.2011.01.014 · Cited by 397
Self-citationHsu, K.-J., Liao, C.-D., Tsai, M.-W., & Chen, C.-N. (2019) · Nutrients · doi:10.3390/nu11092163 · Cited by 258
Current and investigational medications for the treatment of sarcopenia
Rolland, Y., Dray, C., Vellas, B., & Barreto, P. D. S. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155597 · Cited by 195
Metadata
- Authors
- Aubertin-Leheudre, M., Lord, C., Khalil, A., & Dionne, I. J.
- Affiliations
- Centre de recherche sur le vieillissement (CA)
- Université de Sherbrooke (CA)
- Corresponding author
- Dionne, I J
- ORCID
- Venue
- European Journal of Clinical Nutrition
- Published
- 2007-02-21
- Volume
- 61
- Issue
- 12
- Pages
- 1442-1444
- ISSN
- 0954-3007 (ISSN-L)
- 1476-5640
- OpenAlex
- W1967428819
- Cited by
- 70
- References
- 21
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 6 · 2023: 6 · 2022: 3 · 2021: 6 · 2020: 3 · 2019: 3 · 2018: 2 · 2017: 4 · 2016: 1 · 2015: 1 · 2014: 2 · 2013: 2 · 2012: 5
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- European Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Phytoestrogen effects and research
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- isoflavone supplementation, fat-free mass, sarcopenia, obesity, postmenopausal women, muscle mass index, genistein, daidzein, glycitein, body composition
- MeSH terms
- Aged, Aging, Body Composition, Double-Blind Method, Female, Humans, Isoflavones, Middle Aged, Muscular Atrophy, Obesity, Absorptiometry, Photon, Treatment Outcome, Postmenopause, Muscle, Skeletal, Dietary Supplements, Phytoestrogens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Six months of isoflavone supplement increases fat-free mass in obese–sarcopenic postmenopausal women: a randomized double-blind controlled trial. https://app.cochat.ai/papers/10.1038/sj.ejcn.1602695
- The paper
- Aubertin-Leheudre, M., Lord, C., Khalil, A., & Dionne, I. J. (2007). Six months of isoflavone supplement increases fat-free mass in obese–sarcopenic postmenopausal women: a randomized double-blind controlled trial. European Journal of Clinical Nutrition. https://doi.org/10.1038/sj.ejcn.1602695
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.